Ian G. Cannell
- Cancer Research top 5%
- MicroRNA in disease regulation 3
- Cancer-related molecular mechanisms research 2
- Molecular Biology top 10%
- RNA Research and Splicing 6
- RNA modifications and cancer 5
- DNA Repair Mechanisms 5
- CRISPR and Genetic Engineering 3
- Angiogenesis and VEGF in Cancer 2
- Aging top 10%
-
- Cancer-related Molecular Pathways 4
- Co-authors
- Martin BushellYi Wen KongAnne E. WillisMichael B. YaffeHelen C. DobbynSandra MorandellTheresia R. KressMartin Eilers
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Genes & Development (1 paper)Molecular Cell (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Ian G. Cannell
15 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 98
- Cancer Research 555
- Molecular Biology 928
- Aging 19
- Oncology 147
- Obstetrics and Gynecology 38
Countries citing papers authored by Ian G. Cannell
This map shows the geographic impact of Ian G. Cannell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian G. Cannell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian G. Cannell more than expected).
Fields of papers citing papers by Ian G. Cannell
This network shows the impact of papers produced by Ian G. Cannell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian G. Cannell. The network helps show where Ian G. Cannell may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ian G. Cannell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 11 | |
| 3 | 2023 | 22 | |
| 4 | 2022 | 6 | |
| 5 | 2020 | 29 | |
| 6 | 2015 | 69 | |
| 7 | 2015 | 32 | |
| 8 | 2013 | 73 | |
| 9 | 2012 | 116 | |
| 10 | 2011 | 32 | |
| 11 | 2011 | 118 | |
| 12 | 2010 | 147 | |
| 13 | 2010 | 56 | |
| 14 | 2008 | 153 | |
| 15 | 2008 | 320 |
About Ian G. Cannell
Ian G. Cannell is a scholar working on Cancer Research, Oncology and Modeling and Simulation, having authored 15 papers that have together received 1.2k indexed citations. Recurring topics across this work include RNA Research and Splicing (6 papers), RNA modifications and cancer (5 papers), DNA Repair Mechanisms (5 papers), Cancer-related Molecular Pathways (4 papers), CRISPR and Genetic Engineering (3 papers), MicroRNA in disease regulation (3 papers), Angiogenesis and VEGF in Cancer (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Cancer Research (555 citations), Molecular Biology (928 citations) and Aging (19 citations). Ian G. Cannell has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Martin Bushell, Yi Wen Kong, Anne E. Willis, Michael B. Yaffe, Helen C. Dobbyn, Sandra Morandell, Theresia R. Kress, Martin Eilers, Matthias Gaestel and Hans Christian Reinhardt. Their work appears in journals such as Proceedings of the National Academy of Sciences, Genes & Development and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.